In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Medtronic buys VidaMed for $326mm in cash

Executive Summary

Medtronic has agreed to acquire VidaMed (minimally invasive urological surgery devices) for $326mm in cash. Medtronic will pay VidaMed shareholders $7.91 per share (a 35% premium to market average) for all outstanding equity of VidaMed. VidaMed will become a wholly owned subsidiary of Medtronic.
Deal Industry
  • Medical Devices
  • Medical Devices
    • Radiofrequency Devices
    • Surgical Equipment & Devices
Deal Status
  • Final
Deal Type
  • Acquisition
    • Full Acquisition
    • Includes Contract
    • Payment Includes Cash

Related Companies